Literature DB >> 9548893

Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery.

S Tenjarla1, P Puranajoti, R Kasina, T Mandal.   

Abstract

The solubility of miconazole in water increased in the presence of cyclodextrins (CDs). The apparent K1:1 values calculated from the phase solubility diagrams of gamma-CD, hydroxypropyl-beta-CD, alpha-CD, hydroxyethyl-beta-CD, hydroxypropyl-gamma-CD, and beta-CD were 695 +/- 39.6, 363 +/- 34.1, 333 +/- 18.5, 312 +/- 31.0, 305 +/- 27.6, and 293 +/- 17.6 M(-1), respectively. Solid 1:1 molar complexes were prepared by freeze-drying and kneading and characterized by UV spectroscopy, differential scanning calorimetry, and electron microscopy. The dissolution rate increased to 28-255-fold and the solubility to 9-55-fold. Oral bioavailability in rats increased to 2.3-fold by complexation with hydroxypropyl-beta-CD. Human cadaver skin retained 2.6-fold more drug from the miconazole/alpha-CD complex and hairless mice skin retained 8.4-fold more drug from the HP-beta-CD complex than from miconazole solution alone in 24 h.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548893     DOI: 10.1021/js970361l

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Transdermal delivery of cyclodextrin-solubilized curcumin.

Authors:  Raksha Ghanghoria; Prashant Kesharwani; Hrushikesh Bharat Agashe; N K Jain
Journal:  Drug Deliv Transl Res       Date:  2013-06       Impact factor: 4.617

2.  Oral bioavailability in pigs of a miconazole/hydroxypropyl-gamma-cyclodextrin/L-tartaric acid inclusion complex produced by supercritical carbon dioxide processing.

Authors:  Valéry Barillaro; Brigitte Evrard; Luc Delattre; Géraldine Piell
Journal:  AAPS J       Date:  2005-08-18       Impact factor: 4.009

3.  Clotrimazole-cyclodextrin based approach for the management and treatment of Candidiasis - A formulation and chemistry-based evaluation.

Authors:  Noorullah Naqvi Mohammed; Pankaj Pandey; Nayaab S Khan; Khaled M Elokely; Haining Liu; Robert J Doerksen; Michael A Repka
Journal:  Pharm Dev Technol       Date:  2015-04-29       Impact factor: 3.133

4.  Antifungal activity, biofilm-controlling effect, and biocompatibility of poly(N-vinyl-2-pyrrolidinone)-grafted denture materials.

Authors:  Xinbo Sun; Zhengbing Cao; Chih-Ko Yeh; Yuyu Sun
Journal:  Colloids Surf B Biointerfaces       Date:  2013-04-30       Impact factor: 5.268

5.  Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.

Authors:  Andreza Ribeiro; Ana Figueiras; Delfim Santos; Francisco Veiga
Journal:  AAPS PharmSciTech       Date:  2008-10-31       Impact factor: 3.246

6.  Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits.

Authors:  Yazeed Hm Aljimaee; Abdel-Rahim M El-Helw; Osama Aa Ahmed; Khalid M El-Say
Journal:  Drug Des Devel Ther       Date:  2015-03-05       Impact factor: 4.162

7.  Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity.

Authors:  Bader Mubarak Aljaeid; Khaled Mohamed Hosny
Journal:  Int J Nanomedicine       Date:  2016-01-25

8.  Impact of azole drugs on energetics, kinetics, and ligand migration pathways of CO photo-dissociation in bacterial flavohemoglobins.

Authors:  David Butcher; Myriam Moussaoui; Laura Baciou; Jaroslava Miksovska
Journal:  RSC Adv       Date:  2020-05-10       Impact factor: 3.361

9.  A Study on Improvement of Solubility of Rofecoxib and its effect on Permeation of Drug from Topical Formulations.

Authors:  Madhur Kulkarni; Mangal Nagarsenker
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

10.  Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.

Authors:  Abdurrahman M Fahmy; Doaa Ahmed El-Setouhy; Ahmed B Ibrahim; Basant A Habib; Saadia A Tayel; Noha A Bayoumi
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.